GRAIL, Inc.GRAL決算レポート
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
GRAL Q4 2025 Key Financial Metrics
売上高
$43.6M
粗利益
N/A
営業利益
$-124.4M
純利益
$-99.2M
粗利益率
N/A
営業利益率
-285.4%
純利益率
-227.5%
前年比成長
14.0%
EPS
$-2.37
資金フロー
GRAIL, Inc. Q4 2025 財務サマリー
GRAIL, Inc. reported revenue of $43.6M (up 14.0% YoY) for Q4 2025, with a net profit of $-99.2M (down 2.2% YoY) (-227.5% margin). Cost of goods sold was N/A.
主要財務指標
| 総売上高 | $43.6M |
|---|---|
| 純利益 | $-99.2M |
| 粗利益率 | N/A |
| 営業利益率 | -285.4% |
| 報告期間 | Q4 2025 |
売上内訳
GRAIL, Inc. Q4 2025 revenue of $43.6M breaks down across 2 segments, led by Screening Revenue at $42.3M (97.0% of total).
| セグメント | 売上高 | 構成比 |
|---|---|---|
| Screening Revenue | $42.3M | 97.0% |
| Developmental Services Revenue | $1.3M | 3.0% |
GRAIL, Inc. セグメント別売上 — 四半期推移
GRAIL, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Screening Revenue and Developmental Services Revenue) has evolved quarter over quarter.
| セグメント | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Screening Revenue | $42.3M | $32.8M | $34.4M | $29.1M |
| Developmental Services Revenue | $1.3M | $3.4M | $1.2M | $2.7M |
GRAIL, Inc. 年度売上推移
GRAIL, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $147.2M). Click any linked year to see what changed vs the prior 10-K.
GRAIL, Inc. 四半期売上・純利益の履歴
GRAIL, Inc. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $43.6M | +14.0% | $-99.2M | -227.5% |
| Q3 2025 | $36.2M | +26.3% | $-89.0M | -245.8% |
| Q2 2025 | $35.5M | +11.2% | $-114.0M | -320.7% |
| Q1 2025 | $31.8M | +19.1% | $-106.2M | -333.6% |
| Q4 2024 | $38.3M | +84.6% | $-97.1M | -253.8% |
| Q3 2024 | $28.7M | — | $-125.7M | -438.7% |
| Q2 2024 | $32.0M | +42.6% | $-1.6B | -4958.8% |
| Q1 2024 | $26.7M | — | $-218.9M | -819.3% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $26.7M | $32.0M | $28.7M | $38.3M | $31.8M | $35.5M | $36.2M | $43.6M |
| 前年比成長 | N/A | 42.6% | N/A | 84.6% | 19.1% | 11.2% | 26.3% | 14.0% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | N/A | $3.27B | $3.12B | $2.98B | $2.85B | $2.70B | $2.60B | $2.92B |
| 総負債 | N/A | $574.5M | $530.3M | $479.9M | $433.9M | $387.9M | $361.1M | $344.2M |
| 株主資本 | N/A | $2.70B | $2.59B | $2.50B | $2.41B | $2.31B | $2.24B | $2.58B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| 営業CF | $-207.3M | $-171.8M | $-104.6M | $-95.0M | $-77.0M | $-63.2M | $-63.8M |